サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1620154

血管組織マトリックスの世界市場レポート 2024年

Vascular Tissue Matrix Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
血管組織マトリックスの世界市場レポート 2024年
出版日: 2024年12月20日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管組織マトリックス市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR8.0％で16億3,000万米ドルに成長します。予測期間中の成長は、心血管疾患（CVDs）の罹患率上昇、再生医療の進歩、臓器・組織提供の認知度向上、政府の取り組みと資金提供によるものと考えられます。予測期間の主要動向としては、共同研究やパートナーシップ、生分解性マトリックスや生体工学的マトリックスの出現、意識の高まりと早期診断、政府の支援策、医療インフラの拡大などが挙げられます。

低侵襲処置の採用が増加していることが、血管組織マトリックス市場の成長を促進すると予想されます。小さな切開を伴う、あるいは切開を伴わない低侵襲手術は、従来の手術に比べて回復時間が早い、合併症のリスクが低い、術後の痛みが少ないなどの利点があり、人気を集めています。血管組織マトリックスは、大がかりな手術を必要とせずに血管の支持と再生を助けるため、こうした手術に不可欠です。例えば、2024年1月、米国のロボットシステムメーカーであるIntuitive Surgical Inc.は、2023年第4四半期に同社のダヴィンチ手術システムの設置台数が12％増加したと報告し、低侵襲アプローチに対する需要の高まりを強調しています。その結果、低侵襲手術の成長が血管組織マトリックス市場を押し上げています。

血管組織マトリックス市場の各社は、ヒト臍帯細胞外マトリックス（ECM）由来の組織マトリックスなど、競争優位性を獲得するための革新的製品の開発に注力しています。臍帯のECMに由来する構造タンパク質や分子からなるこれらの組織マトリックスは、細胞浸潤や組織再生をサポートする骨格として機能します。例えば、米国を拠点とするバイオテクノロジー企業StimLabs LLCは2024年2月、ヒト臍帯ECM由来の創傷治療器具Corplex Pについて、米国食品医薬品局（FDA）から510（k）認可を取得しました。この新規製品は、糖尿病性潰瘍、褥瘡、手術創、外傷創など様々なタイプの創傷を治療するよう設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の血管組織マトリックス市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の血管組織マトリックス市場の実績：規模と成長、2018～2023年
  • 世界の血管組織マトリックス市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の血管組織マトリックス市場：タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • 生物学的マトリックス
  • 合成マトリックス
  • 世界の血管組織マトリックス市場：治療領域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 整形外科
  • 皮膚科
  • 心臓病学
  • 神経学
  • 腫瘍学
  • その他
  • 世界の血管組織マトリックス市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • クリニック
  • その他

第7章 地域別・国別分析

  • 世界の血管組織マトリックス市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の血管組織マトリックス市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 血管組織マトリックス市場：競合情勢
  • 血管組織マトリックス市場：企業プロファイル
    • Abbott Laboratories
    • Medtronic PLC
    • Stryker Corporation
    • Baxter International Inc.
    • Boston Scientific Corporation

第31章 その他の大手企業と革新的企業

  • Terumo Corporation
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates Inc.
  • Coloplast Group
  • Getinge Group
  • Integra LifeSciences Corporation
  • LivaNova PLC
  • C. R. Bard Inc.
  • Artivion Inc.
  • CryoLife Inc.
  • LeMaitre Vascular Inc.
  • Kensey Nash Corporation
  • Cardiva Medical Inc.
  • Lombard Medical Technologies
  • Genzyme Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20901

A vascular tissue matrix is a biomaterial scaffold designed to support the growth, repair, or regeneration of vascular tissues, which include arteries, veins, and capillaries. This matrix offers a three-dimensional structure that simulates the extracellular matrix (ECM) of natural vascular tissues, aiding in cell attachment, proliferation, and differentiation.

The main types of vascular tissue matrices are biologic and synthetic matrices. A biologic matrix is derived from natural tissues and cells, typically sourced from humans or animals. These matrices are used in medical procedures to replace or repair damaged tissues, facilitating natural healing by integrating with the body's own tissues. They find applications in various therapeutic fields such as orthopedics, dermatology, cardiology, neurology, oncology, and more, and are utilized in settings like hospitals and clinics.

The vascular tissue matrix market research report is one of a series of new reports from The Business Research Company that provides vascular tissue matrix market statistics, including vascular tissue matrix industry global market size, regional shares, competitors with a vascular tissue matrix market share, detailed vascular tissue matrix market segments, market trends and opportunities, and any further data you may need to thrive in the vascular tissue matrix industry. This vascular tissue matrix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular tissue matrix market size has grown strongly in recent years. It will grow from $1.11 billion in 2023 to $1.20 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historical period can be credited to progress in tissue engineering, an aging population, an increasing number of surgical procedures, and the advancement of biocompatible materials.

The vascular tissue matrix market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to the rising incidence of cardiovascular diseases (CVDs), advancements in regenerative medicine, increased awareness of organ and tissue donation, and government initiatives and funding. Key trends for the forecast period include collaborations and partnerships, the emergence of biodegradable and bioengineered matrices, growing awareness and early diagnosis, supportive government initiatives, and the expansion of healthcare infrastructure.

The increasing adoption of minimally invasive procedures is expected to drive the growth of the vascular tissue matrix market. Minimally invasive procedures, which involve small or no incisions, are gaining popularity due to their advantages, such as faster recovery times, reduced risk of complications, and less post-operative pain compared to traditional surgeries. Vascular tissue matrices are essential in these procedures as they help support and regenerate blood vessels without requiring extensive surgery. For example, in January 2024, Intuitive Surgical Inc., a U.S.-based manufacturer of robotic systems, reported a 12% increase in the placement of their da Vinci surgical systems in the fourth quarter of 2023, highlighting the rising demand for minimally invasive approaches. As a result, the growth of minimally invasive procedures is boosting the vascular tissue matrix market.

Companies in the vascular tissue matrix market are focusing on developing innovative products, such as tissue matrices derived from human umbilical cord extracellular matrix (ECM), to gain a competitive edge. These tissue matrices, composed of structural proteins and molecules from the umbilical cord's ECM, serve as scaffolds for supporting cellular infiltration and tissue regeneration. For instance, in February 2024, StimLabs LLC, a U.S.-based biotechnology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Corplex P, a wound care device derived from human umbilical cord ECM. This novel product is designed to treat various types of wounds, including diabetic ulcers, pressure ulcers, surgical wounds, and trauma wounds.

In April 2023, Aziyo Biologics, a U.S.-based regenerative medicine company, partnered with LeMaitre Vascular Inc. to exclusively distribute its cardiovascular product line in the United States. This collaboration includes products made from an extracellular matrix derived from porcine small intestine submucosa, which are designed to enhance healing and reduce inflammation in surgical applications. LeMaitre Vascular Inc. is a U.S.-based medical device company that offers vascular tissue matrix products as part of its cardiovascular portfolio.

Major companies operating in the vascular tissue matrix market are Abbott Laboratories, Medtronic PLC, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Coloplast Group, Getinge Group, Integra LifeSciences Corporation, LivaNova PLC, C. R. Bard Inc., Artivion Inc., CryoLife Inc., LeMaitre Vascular Inc., Kensey Nash Corporation, Cardiva Medical Inc., Lombard Medical Technologies, Genzyme Corporation, Cook Medical Inc., Humacyte Inc., BioCardia Inc.

North America was the largest region in the vascular tissue matrix market in 2023. The regions covered in the vascular tissue matrix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vascular tissue matrix market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular tissue matrix market consists of sales of wound care devices, stent grafts, vascular filters, and synthetic vascular grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Tissue Matrix Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular tissue matrix market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular tissue matrix ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular tissue matrix market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Biologic Matrix; Synthetic Matrix
  • 2) By Therapeutic Area: Orthopedics; Dermatology; Cardiology; Neurology; Oncology; Others Therapeutic
  • 3) By Application: Hospital; Clinic; Other Applications
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Stryker Corporation; Baxter International Inc.; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Tissue Matrix Market Characteristics

3. Vascular Tissue Matrix Market Trends And Strategies

4. Vascular Tissue Matrix Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Vascular Tissue Matrix Market Size and Growth

  • 5.1. Global Vascular Tissue Matrix Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Vascular Tissue Matrix Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Vascular Tissue Matrix Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vascular Tissue Matrix Market Segmentation

  • 6.1. Global Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biologic Matrix
  • Synthetic Matrix
  • 6.2. Global Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Orthopedics
  • Dermatology
  • Cardiology
  • Neurology
  • Oncology
  • Others Therapeutic Areas
  • 6.3. Global Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Clinic
  • Other Applications

7. Vascular Tissue Matrix Market Regional And Country Analysis

  • 7.1. Global Vascular Tissue Matrix Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Vascular Tissue Matrix Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vascular Tissue Matrix Market

  • 8.1. Asia-Pacific Vascular Tissue Matrix Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vascular Tissue Matrix Market

  • 9.1. China Vascular Tissue Matrix Market Overview
  • 9.2. China Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vascular Tissue Matrix Market

  • 10.1. India Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vascular Tissue Matrix Market

  • 11.1. Japan Vascular Tissue Matrix Market Overview
  • 11.2. Japan Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vascular Tissue Matrix Market

  • 12.1. Australia Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vascular Tissue Matrix Market

  • 13.1. Indonesia Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vascular Tissue Matrix Market

  • 14.1. South Korea Vascular Tissue Matrix Market Overview
  • 14.2. South Korea Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vascular Tissue Matrix Market

  • 15.1. Western Europe Vascular Tissue Matrix Market Overview
  • 15.2. Western Europe Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vascular Tissue Matrix Market

  • 16.1. UK Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vascular Tissue Matrix Market

  • 17.1. Germany Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vascular Tissue Matrix Market

  • 18.1. France Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vascular Tissue Matrix Market

  • 19.1. Italy Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vascular Tissue Matrix Market

  • 20.1. Spain Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vascular Tissue Matrix Market

  • 21.1. Eastern Europe Vascular Tissue Matrix Market Overview
  • 21.2. Eastern Europe Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vascular Tissue Matrix Market

  • 22.1. Russia Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vascular Tissue Matrix Market

  • 23.1. North America Vascular Tissue Matrix Market Overview
  • 23.2. North America Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vascular Tissue Matrix Market

  • 24.1. USA Vascular Tissue Matrix Market Overview
  • 24.2. USA Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vascular Tissue Matrix Market

  • 25.1. Canada Vascular Tissue Matrix Market Overview
  • 25.2. Canada Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vascular Tissue Matrix Market

  • 26.1. South America Vascular Tissue Matrix Market Overview
  • 26.2. South America Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vascular Tissue Matrix Market

  • 27.1. Brazil Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vascular Tissue Matrix Market

  • 28.1. Middle East Vascular Tissue Matrix Market Overview
  • 28.2. Middle East Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vascular Tissue Matrix Market

  • 29.1. Africa Vascular Tissue Matrix Market Overview
  • 29.2. Africa Vascular Tissue Matrix Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Vascular Tissue Matrix Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Vascular Tissue Matrix Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vascular Tissue Matrix Market Competitive Landscape And Company Profiles

  • 30.1. Vascular Tissue Matrix Market Competitive Landscape
  • 30.2. Vascular Tissue Matrix Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Medtronic PLC
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Stryker Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Baxter International Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Boston Scientific Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Vascular Tissue Matrix Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Edwards Lifesciences Corporation
  • 31.3. W. L. Gore & Associates Inc.
  • 31.4. Coloplast Group
  • 31.5. Getinge Group
  • 31.6. Integra LifeSciences Corporation
  • 31.7. LivaNova PLC
  • 31.8. C. R. Bard Inc.
  • 31.9. Artivion Inc.
  • 31.10. CryoLife Inc.
  • 31.11. LeMaitre Vascular Inc.
  • 31.12. Kensey Nash Corporation
  • 31.13. Cardiva Medical Inc.
  • 31.14. Lombard Medical Technologies
  • 31.15. Genzyme Corporation

32. Global Vascular Tissue Matrix Market Competitive Benchmarking

33. Global Vascular Tissue Matrix Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Vascular Tissue Matrix Market

35. Vascular Tissue Matrix Market Future Outlook and Potential Analysis

  • 35.1 Vascular Tissue Matrix Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Vascular Tissue Matrix Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Vascular Tissue Matrix Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer